Skip to Content
Merck
  • Osteogenic activity of diphenyl ether-type cyclic diarylheptanoids derived from Acer nikoense.

Osteogenic activity of diphenyl ether-type cyclic diarylheptanoids derived from Acer nikoense.

Bioorganic & medicinal chemistry letters (2011-05-10)
Takayuki Yonezawa, Ji-Won Lee, Hiroyuki Akazawa, Masahiko Inagaki, Byung-Yoon Cha, Kazuo Nagai, Kazumi Yagasaki, Toshihiro Akihisa, Je-Tae Woo
ABSTRACT

Osteogenic activity of six diarylheptanoids, acerogenin A (1), (R)-acerogenin B (2), aceroside I (3), aceroside B(1) (4), aceroside III (5) and (-)-centrolobol (6) and two phenolic compounds; (+)-rhododendrol (7) and (+)-cathechin (8), isolated from the stem bark of Acer nikoense (Nikko maple) was evaluated using alkaline phosphatase (ALP) activity as a marker for early osteoblast differentiation. We found that the diphenyl ether-type cyclic diarylheptanoids 1-5 promoted ALP activity in mouse preosteoblastic MC3T3-E1 cells without affecting cell proliferation, but linear-type diarylheptanoid 6 and phenolic compounds 7 and 8 did not. Diphenyl ether-type cyclic diarylheptanoids 1-4 also increased protein production of osteocalcin, a late stage maker for osteoblast differentiation, and induced osteoblastic mineralization. Structure-activity relationships of these compounds demonstrated that the stimulative efficacy of aglycones was higher than that of its glycosides. Taken together, diphenyl ether-type cyclic diarylheptanoids promote early- and late-stage osteoblastogenesis, which may open the possibility for the development of novel osteogenic agents.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Diphenyl ether, ≥99%, FG
Supelco
Diphenyl ether, Selectophore, ≥99.9%
Sigma-Aldrich
Diphenyl ether, ReagentPlus®, ≥99%
Sigma-Aldrich
Diphenyl ether, ReagentPlus®, 99%